{"title":"What are the Tensional Goals in the Frail Elderly?","authors":"Rita Nascimento","doi":"10.33552/ojcr.2019.03.000562","DOIUrl":null,"url":null,"abstract":"In the present study we performed a literature review, aiming to understand the practical applicability of this new guidelines in the older people, and especially in frail elderly. We searched on the online database “Pubmed” the MESH terms “Hypertension” and “Frail Elderly” and we selected 32 out of 76 papers published in the last 10 years; from this 32 we selected the ones that approached the treatment targets for blood pressure. This research was complemented with the inclusion of other international guidelines and papers that were found relevant. From the papers selected to perform this review, we found guidelines, reviews and observational studies, some with conflicting results and others that are unable to define a blood pressure target in frail and institutionalized elderly. Hypertension is a well stablished cardiovascular (CV) risk factor in adults, active independent older people and even in frail elderly; nevertheless in the group of frail elderly there is evidence that they might lack a benefit in the aggressive treatment of high blood pressure. The randomized controlled trials from Beckett N, et al. [1] and Briasoulis A, et al. [2] showed that the hypertension treatment in older patients (age ≥65 years) and very old patients (≥80 years) significantly reduced CV morbidity and CV and all-cause mortality. In this studies treatment of hypertension was found to be well tolerated. The 2018 ESC/ESH guidelines recommend systolic blood pressure (SBP) target at 130-139 mmHg and diastolic blood pressure (DBP) under 80 mmHg for elderly above 65 years. The American guidelines (2017) recommend SBP under 130 mmHg for community dwelling older people above 65 years, but also recommend wariness in the risk-benefit relation, presence of comorbidities and limited life span. The Canadian guidelines (2018) refer to a lack of evidence to make a recommendation in blood pressure targets in institutionalized elderly [3]. The Australian guidelines (2016) recommend a target of SPB under 120 mmHg and the British (2017) omit a recommendation referring to targets in this population.","PeriodicalId":289086,"journal":{"name":"Online Journal of Cardiovascular Research","volume":"79 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Online Journal of Cardiovascular Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33552/ojcr.2019.03.000562","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
In the present study we performed a literature review, aiming to understand the practical applicability of this new guidelines in the older people, and especially in frail elderly. We searched on the online database “Pubmed” the MESH terms “Hypertension” and “Frail Elderly” and we selected 32 out of 76 papers published in the last 10 years; from this 32 we selected the ones that approached the treatment targets for blood pressure. This research was complemented with the inclusion of other international guidelines and papers that were found relevant. From the papers selected to perform this review, we found guidelines, reviews and observational studies, some with conflicting results and others that are unable to define a blood pressure target in frail and institutionalized elderly. Hypertension is a well stablished cardiovascular (CV) risk factor in adults, active independent older people and even in frail elderly; nevertheless in the group of frail elderly there is evidence that they might lack a benefit in the aggressive treatment of high blood pressure. The randomized controlled trials from Beckett N, et al. [1] and Briasoulis A, et al. [2] showed that the hypertension treatment in older patients (age ≥65 years) and very old patients (≥80 years) significantly reduced CV morbidity and CV and all-cause mortality. In this studies treatment of hypertension was found to be well tolerated. The 2018 ESC/ESH guidelines recommend systolic blood pressure (SBP) target at 130-139 mmHg and diastolic blood pressure (DBP) under 80 mmHg for elderly above 65 years. The American guidelines (2017) recommend SBP under 130 mmHg for community dwelling older people above 65 years, but also recommend wariness in the risk-benefit relation, presence of comorbidities and limited life span. The Canadian guidelines (2018) refer to a lack of evidence to make a recommendation in blood pressure targets in institutionalized elderly [3]. The Australian guidelines (2016) recommend a target of SPB under 120 mmHg and the British (2017) omit a recommendation referring to targets in this population.
在目前的研究中,我们进行了文献综述,旨在了解这一新指南在老年人,特别是在体弱老年人中的实际适用性。我们在网络数据库Pubmed中检索MESH术语“Hypertension”和“虚弱的老年人”,从近10年发表的76篇论文中选择32篇;从这32种药物中,我们选择了接近血压治疗目标的药物。这项研究还纳入了其他被认为相关的国际准则和论文。从进行本综述的论文中,我们找到了指南、综述和观察性研究,其中一些结果相互矛盾,另一些则无法确定体弱和机构老年人的血压目标。高血压是成年人、活跃的独立老年人甚至体弱老年人中公认的心血管(CV)危险因素;然而,在体弱多病的老年人群体中,有证据表明他们在积极治疗高血压方面可能缺乏益处。Beckett N, et al.[1]和Briasoulis A, et al.[2]的随机对照试验表明,老年患者(≥65岁)和高龄患者(≥80岁)的高血压治疗可显著降低CV发病率、CV和全因死亡率。在这项研究中,发现高血压的治疗耐受性良好。2018年ESC/ESH指南建议65岁以上老年人收缩压(SBP)目标为130-139 mmHg,舒张压(DBP)低于80 mmHg。美国指南(2017)建议65岁以上社区居民的收缩压低于130 mmHg,但也建议注意风险-收益关系、合并症的存在和有限的寿命。加拿大指南(2018)指出,缺乏证据建议机构老年人的血压目标[3]。澳大利亚指南(2016年)建议将SPB目标控制在120毫米汞柱以下,英国指南(2017年)省略了针对这一人群的目标的建议。